Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 219-226

  Asimakopoulos, F A ^a   Green, A R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Chromosome 20; Myelodysplastic syndromes; Myeloproliferative disorders

Indexed keywords

CHROMOSOME 20Q; CHROMOSOME DELETION; HUMAN; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW;

EID: 0029825270     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1896.x     Document Type: Review

References (70)

1. Aatola, M., Armstrong, E., Teerenhovi, I., & Borgstrom, G.H. (1992) Clinical significance of the del(20q) chromosome in hematologic disorders. Cancer Genetics and Cytogenetics, 62, 75-80.
2. Abrahamson, G., Boultwood, J., Madden, J., Kelly, S., Oscier, D.G., Rack, K., Buckle, V.J. & Wainscoat, J.S. (1991) Clonality of cell populations in refractory anaemia uising combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. British Journal of Haematology. 79. 550-555.
3. Aldred, M.A., Humphray, S.J., Gwillian, R., Bench, A., Bentley, D.R. & Green, A.R. (1996) A YAC contig spanning the region of chromosome 20q that is detected in myeloproliferative disorders, HGM' 96 Abstract Book, p. 2.
4. Amenomori, T., Tomonaga, M., Yoshida, Y., Kuriyama, K., Matsuo, T., Jinnai, I., Ichimaru, M., Omiya, A. & Tsuji, Y. (1986) Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvenile chronic myeloid leukaemia. British Journal of Haematology, 64, 539-546.
5. Argyrokastritis, A., Kamakari, S., Kapsetaki, M., Kritis, A., Talianidis, I. & Moschonas, N.K. (1996) hHNF-4B and HNF-4C gene loci map to chromosome 20q12-q13.2 and are closely linked. HGM' 96 Abstract Book, p. 4.
6. Ashburner, M. (1989) Drosophila: a Laboratory Handbook, Cold Spring Harbor Laboratory Press, New York.
7. Asimakopoulos, F.A., Gilbert, J.G.R., Aldred, M.A., Pearson, T.C. & Green, A.R. (1996a) Interstitial deletion constitutes the main mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood, in press.
8. Asimakopoulos, F.A., Holloway, T.L., Nacheva, E.P., Scott, M.A., Fenaux, P. & Green, A.R. (1996b) Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes, Blood 87, 1561-1570.
9. Asimakopoulos, F.A., White, N., Nacheva, E. & Green, A.R. (1994) Molecular analysis of chromosome 20 deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood, 84, 3086-3094.
10. Asimakopoulos, F.A., White, N.J., Nacheva, E.P. & Green, A.R. (1996c) The human CD40 gene lies within chromosome 20q deletions associated with myeloid malignancies. British Journal of Haematology, 92, 127-130.
11. Avraham, K.B., Prezioso, V.R., Chen, W.S., Lai, E., Sladek, F.M., Zhong, W., Darnell, J.E., Jr, Jenkins, N.A. & Copeland, N.G. (1992) Murine chromosomal location of four hepatocyte enriched transcription factors: HNF-3a, HNF-33, HF-3 , and HNF-4. Genomics, 13, 264-268.
12. Campbell, L.J. & Garson, O.M. (1994) The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia, 8, 67-71.
13. Culligan, D.J., Cachia, P., Whittaker, J., Jacobs, A. & Padua, R.A. (1992) Clonal lymphocytes are detectable in only some cases of MDS. British Journal of Haematology, 81, 346-352.
14. Davis, M.P., Dewald, G.W., Pierre, R.V. & Hoagland, H.C. (1984) Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genetics and Cytogenetics, 12, 63-71.
15. Demory, J.L., Dupriez, B., Fenaux, P., Lai, J.L., Beuscart, R., Jouet, J.P., Deminatti, M. & Bauters, F. (1988) Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood, 72, 855-859.
16. Dewald, G.W. & Wright, P.I. (1995) Chromosome abnormalities in the myeloproliferative disorders. Seminars in Oncology. 22, 341-354.
17. Diez-Martin, J.L., Graham, D.L., Pettit, R.M. & Dewald, G.W. (1991) Chromosome studies in 104 patients with polycythemia vera. Mayo Clinic Proceedings, 66, 287-299.
18. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. & Moore, M.W. (1996) Heterozygous embryonic lethality induced by target inactivation of the VEGF gene, Nature, 380, 439-442.
19. Fisher, E. & Scambler, P. (1994) Human haploinsufficiency; one for sorrow, two for joy. Nature Genetics. 7, 5-7.
20. Green, A.R. (1996) Pathogenesis of polycythaemia vera. Lancet, 347, 844-845.
21. Hartl, D.L. (1996) The most unkindest cut of all. Nature Genetics, 12, 227-229.
22. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S.R., Gnarra, J.R., Linehan, W.M. & Baylin, S.B. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma, Proceedings of the National Academy of Sciences of the United States of America, 91, 9700-9704.
23. Hollings, P.E. (1994) Molecular heterogeneity at the breakpoints of smaller 20q deletions. Genes, Chromosomes and Cancer. 11, 21-28.
24. Hollings, P.E., Benjes, S.M., Rosman, I. & Fitzgerald, P.H. (1995) Deletion 20q in association with Philadelphia chromosome positive acute lymphoblastic leukemia: report of two cases. Cancer Genetics and Cytogenetics, 79, 32-35.
25. Janssen, J.W.G., Buschle, M., Layton, M., Drexler, H.G., Lyons, J., van den Berghe, H., Heimpel, H., Kubarek, B., Kleihauer, E., Mufti, G.J. & Bartram, C.R. (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood, 73, 248-254.
26. Janssen, J.W.G., Steenvoorden, A.C.M., Lyons, J., Anger, B., Bohlke, J.U., Bos, J.L., Seliger, H. & Bartram, C.R. (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders and myelodysplastic syndromes. Proceedings of the National Academy of Sciences of the United States of America, 84, 9228-9232.
27. Johansson, B., Mertens, F. & Mitelman, F. (1993) Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes, Chromosomes and Cancer. 8, 205-218.
28. Kay, H.E., Lawler, S.D. & Millard, R.E. (1966) The chromosomes in polycythaemia vera. British Journal of Haematology, 12, 507-528.
29. Kere, J., Ruutu, T., Lachtinen, R. & de la Chapelle, A. (1987) Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. New England Journal of Medicine, 316, 499-503.
30. Knapp, R.H., Dewald, G.W. & Pierre, R.V. (1985) Cytogenetic studies in 174 consecutive patients with preleukemia or meylodysplastic syndromes, Mayo Clinic Proceedings, 60, 507-516.
31. Knuutila, S., Teerenhovi, L., Larramendy, M.L., Elonen, E., Franssila, K.O., Nylund, S.J., Timonen, T., Heinonen, K., Mahlamaki, E., Winqvist, R. & Ruutu, T. (1994) Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms. Genes, Chromosomes and Cancer, 10, 95-102.
32. Kroef, M.J., Fibbe, W.E., Mout, R., Jansen, R.P., Haak, H.L., Wessels, J.W., Van Kamp, H., Willemze, R. & Landegent, J.E. (1993) Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood, 81, 1849-1854.
33. Lawrence, H.J., Broudy, V-.C., Magenis, R.E., Olson, S., Tomar, D., Barton, S., Fitchen, J.H. & Bagby, G.C., Jr (1987) Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias. Blood, 70, 1003-1005.
34. Le Beau, M.M., Westbrook, C.A., Diaz, M.O. & Rowley, J.D. (1985) c-src is consistently conserved in the chromsomal deletion (20q)I observed in myeloid disorders. Proceedings of the National Academy of Sciences of the United States of America, 82, 6692-6696.
35. Merino, A., Madden, K.R., Lane, W.S., Champoux, J.J. & Reinberg, D. (1993) DNA topoisomerase I is involved in both repression and activation of transcription. Nature, 365, 227-232.
36. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. & Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 1, 686-692.
37. Mertens, F., Johansson, B., Heim, S., Kristofferson, U. & Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia, 5, 214-220.
38. Mitelman, F. (1995) Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York.
39. Morris, C.M., Honeybone, L.M. & Hollings, P.E. (1989) Localization of the SRC oncogene to chromosome hand 20q 11.2 and loss of this gene with deletion (20q) in two leukemic patients. Blood, 74, 1768-1773.
40. Mufti, G.J. (1992) Chromosomal deletions in the myelodysplastic syndrome. Leukemia Research, 16, 35-41.
41. Nacheva, E., Holloway, T., Carter, N., Grace, C., White, N. & Green, A.R. (1995) Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Cancer Genetics and Cytogenetics, 80, 87-94.
42. Neuman. W.L., Rubin, C.M., Rios, R.B., Larson, R.A., Le Beau, M.M., Rowley, J.D., Vardiman, J.W., Schwartz, J.L. & Farber, R.A. (1992) Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity for chromosomes 5 and 7 in malignant myeloid disorders. Blood, 79, 1501-1510.
43. Osmond, D.G. (1993) The turnover of B-cell populations. Immunology Today, 14, 34-37.
44. Petrij, F., Giles, R.H., Dauwerse, H.G., Saris, J.J., Hennekam, R.C.M., Masuno, M., Tommerup, N., van Ommen, G.-J.B., Goodman, R.H., Peters, D.J.M. & Breuning, M.H. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature, 376, 348-352.
45. Prchal, J.T. & Prchal, J.F. (1994) Evolving understanding of the cellular defect in polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology. Blood, 83, 1-4.
46. Prchal, J.T., Throckmorton, D.W., Carroll, A.J.D., Fuson, E.W., Gams, R.A. & Prchal, J.F. (1978) A common progenitor for human myeloid and lymphoid cells, Nature, 274, 590-591.
47. Rabbitts, T.H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
48. Ramirez-Solis, R., Liu, P. & Bradley, A. (1995) Chromosome engineering in mice, Nature, 378, 720-724.
49. Raskind, W.H., Tirumali, N., Jacobson, R., Singer, J. & Fialkow, P.J. (1984) Evidence fora multistep pathogenesis of a myelodysplastic syndrome. Bood, 63, 1318-1323.
50. Raza, A., Gezer, S., Mundle, S., Gao, X-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. & Preisler, H. (1995a) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
51. Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S., Wright, V., Adler, S., Loew, J.M. Shott, S., All, S.N. & Preisler, H. (1995b) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. American Journal of Hematology. 48, 143-154.
52. Reeves, B.R., Lobb, D.S. & Lawler, S.D. (1972) Identity of the abnormal F group chromosome associated with polycythemia vera. Human Genetics, 14, 159-161.
53. Rege-Cambrin, G., Mecucci, C. & Tricot, G. (1987) A chromosomal profile of polycythemia. Cancer Genetics and Cytoaenetics, 25, 233-245.
54. Rhee, S.G., Suh, P.-G., Ruy, S.-H. & Lee, S.Y. (1989) Studies of inositol phospholipid-specific phospholipase C. Science, 244, 546-550.
55. Roulston, D., Espinosa, R., Stoffel, M. Bell, G.I. & Le Beau, M.M. (1993) Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. Blood, 82, 3424-3429.
56. Scherer, S.S. & Chance, P.F. (1995) Myelin genes: getting the dosage right. Nature Genetics, 11, 226-228.
57. Shepherd, L., Cameron, C., Galbraith, P., Windsor, S. & Lillicrap, D. (1991) Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia. Leukemia Research, 15, 297-303.
58. Shinohara, T., Takuwa, N., Morishita, K., Ieka, R., Yokota, J., Nakayama, E., Asano, S. & Miwa, S. (1983) Chronic myelomonocytic leukemia with a chromosome abnormality (46,XY.20q-) in all dividing myeloid cells. American Journal of Hematology, 15, 289-293.
59. Sladek, F.M., Zhong, W., Lai, E. & Darnell, J.E., Jr (1990) Liverenriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes and Development, 4, 2353-2365.
60. Stoffel, M., Le Beau, M.M., Espinosa, R., Bohlander, S.F., Le Paslier, D., Cohen, D., Xiang, K.S., Cox, N.J., Fajans, S.S. & Bell, G.I. (1996) A yeast artificial chromosome based map of the region of chromosome 20 containing the diabetes susceptibility gene, MODY1, and a myeloid leukemia related gene, Proceedings of the National Academy of Sciences of the United States of America, 93, 3937-3941.
61. Swolin, B., Weinfeld, A. & Westin, J. (1988) A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course, Blood, 72, 386-395.
62. Tandon, R., Tuason, L., Hoeltge, G. & Lichtin, A. (1995) Clinical characteristics of patients with 20q-chromosome deletion. Blood, 86, (Suppl. 1), 333.
63. Tefferi, A., Thibodeau, S.N. & Solberg, L.A., Jr (1990) Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood, 75, 1770-1773.
64. Testa, J.R., Kinealey, A., Rowley, J.D., Golde, D.W. & Potter, D. (1978) Deletion of the long arm of chromsome 20 [del(20)(q,11)] in myeloid disorders. Blood, 52, 868-877.
65. Tsukamoto, N., Morita, K., Maehara, T., Okamoto, K., Karasawa, M., Omine, M. & Naruse, T. (1993) Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. British Journal of Haematology, 83, 589-594.
66. van Kamp, H., Fibbe, W.E., Jansen, R.P., van der Keur, M., de Graaf, E., Willemze, R. & Landegent, J.E. (1992) Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood, 80, 1774-1780.
67. Wasserman, L.R., Berk, P.D. & Berlin, N.I. (1945) Polycythemia Vera and the Myeloproliferative Disorders. Saunders. Philadelphia.
68. Watlel, F., Lai, J.L., Hebbar, M., Preudhomme, C., Grahek, D., Morel, P., Bauters, F. & Fenaux, P. (1993) De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? Leukemia Research, 17, 921-926.
69. White, N.J., Nacheva, E., Asimakopoulos, F.A., Paul, B. & Green, A.R. (1994) Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood, 83, 2809-2816.
70. Yoshida, Y., Anzai, N. & Kawabata, H. (1995) Apoptosis in myelodysplasia: a paradox or paradigm. Leukemia Research, 19, 887-891.